Helen Jessop
- Oncology top 5%
- Molecular Biology
- Orthopedics and Sports Medicine top 2%
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 10%
- Co-authors
- Lance E. LanyonGul ZamanKarla LeeRosemary F. L. SuswilloAndrew A. PitsillidesSimon C.F. RawlinsonMing ChengTien Hoang
- Topics
- Bone Metabolism and Diseases (7 papers)Estrogen and related hormone effects (7 papers)Bone health and osteoporosis research (4 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Helen Jessop
23 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 568
- Molecular Biology 542
- Orthopedics and Sports Medicine 449
- Pulmonary and Respiratory Medicine 315
- Genetics 284
Countries citing papers authored by Helen Jessop
This map shows the geographic impact of Helen Jessop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Jessop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Jessop more than expected).
Fields of papers citing papers by Helen Jessop
This network shows the impact of papers produced by Helen Jessop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Jessop. The network helps show where Helen Jessop may publish in the future.
Co-authorship network of co-authors of Helen Jessop
This figure shows the co-authorship network connecting the top 25 collaborators of Helen Jessop. A scholar is included among the top collaborators of Helen Jessop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Jessop. Helen Jessop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trialbreakdown → | 405 |
| 4 | 3 | |
| 5 | 15 | |
| 6 | 101 | |
| 7 | 82 | |
| 8 | 73 | |
| 9 | 246 | |
| 10 | 46 | |
| 11 | 121 | |
| 12 | 100 | |
| 13 | 83 | |
| 14 | 19 | |
| 15 | 4 | |
| 16 | 5 | |
| 17 | 23 | |
| 18 | 5 | |
| 19 | 6 | |
| 20 | 13 |
About Helen Jessop
Helen Jessop is a scholar working on Microbiology, Orthopedics and Sports Medicine and Endocrinology, having authored 23 papers that have together received 1.4k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (7 papers), Estrogen and related hormone effects (7 papers) and Bone health and osteoporosis research (4 papers). The work is most often cited by research in Orthopedics and Sports Medicine (449 citations), Oncology (568 citations) and Genetics (284 citations). Helen Jessop has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Lance E. Lanyon, Gul Zaman, Karla Lee, Rosemary F. L. Suswillo, Andrew A. Pitsillides, Simon C.F. Rawlinson, Ming Cheng, Tien Hoang, Mark L. McCleland and Daniil Stroyakovskiy. Their work appears in journals such as Nature, Cancer Research and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.